METABOLIC PATTERNS AND CLINICAL RESPONSE TO LEVODOPA THERAPY IN PARKINSONS-DISEASE

被引：0
作者：
MESSIHA, FS
KNOPP, W
机构：
[1] OHIO STATE UNIV,COLL MED,DEPT PSYCHIAT,COLUMBUS,OH
[2] MARYLAND PSYCHIAT RES CTR,PHARMACOL UNIT,BALTIMORE,MD
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1973年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：565 / 571
页数：7
相关论文
共 37 条
[1]   INTERFERENCE IN FLUOROMETRIC QUANTITATION OF URINARY 5-HYDROXYINDOLEACETIC ACID BY ASPIRIN [J].
AHLBERG, CD .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (02) :497-&
[2]  
ANDEN NE, 1970, ACTA MED SCAND, V187, P247
[3]   INHIBITION OF CATECHOL-O-METHYL TRANSFERASE BY L-DOPA AND DECARBOXYLASE INHIBITORS [J].
BALDESSA.RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (01) :78-&
[4]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[5]  
BARBEAU A, 1968, AGGRESSOLOGY, V9, P2
[6]  
BARTHOLINI G, 1968, J PHARMACOL EXP THER, V161, P14
[7]   METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE [J].
BIANCHINE, JR ;
CALIMLIM, LR ;
MORGAN, JP ;
DUJUVNE, CA ;
LASAGNA, L .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :126-+
[8]  
BUNN GG, 1971, EXPERIENTIA, V27, P516
[9]   METABOLISM OF ORALLY ADMINISTERED L-DOPA IN PARKINSONISM [J].
CALNE, DB ;
KAROUM, F ;
RUTHVEN, CRJ ;
SANDLER, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1969, 37 (01) :57-+
[10]   LONG-TERM TREATMENT OF PARKINSONS DISEASE WITH LEVODOPA [J].
CAMPBELL, JB .
NEUROLOGY, 1970, 20 (12) :18-&
1234